US 7265208
Fusion molecules and treatment of IgE-mediated allergic diseases
granted A61KA61K2039/505A61P
Quick answer
US patent 7265208 (Fusion molecules and treatment of IgE-mediated allergic diseases) held by The Regents of the University of California expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/04, A61P1/08